Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
Bone Metastases
Brain Cancer
Business Management
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Genitourinary Cancers
Head & Neck Cancers
Hematologic Oncology
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Non-Hodgkin Lymphoma
Oncology Nursing News
Patient Resources
Sarcomas/TGCT
Special Reports in Personalized Cancer Care
Supportive Care
Online CME
Interactive Publications
SELECT A TOPIC
CURRENT VIEW
All Specialties
▲
Education ▲
Education ▼
Register
|
Login
Conference Coverage
Videos
NewsNetwork
OncLive
®
TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
More >>
OncLive TV: Joyce A. O’Shaughnessy, MD
<< Back to Our Featured Experts
Dr. O'Shaughnessy on Role of Chemotherapy in Future TNBC Treatment
Dr. O'Shaughnessy Discusses New Developments in Molecular Profiling in Breast Cancer
Dr. O'Shaughnessy on Using Phosphoprotein Assays to Personalize Treatment for Breast Cancer
Dr. O'Shaughnessy on Adding Phosphoprotein Testing to Genomic Testing for Breast Cancer
Dr. O'Shaughnessy on Phosphoprotein Assays for Treatment Decision-Making for Breast Cancer
Dr. O'Shaughnessy on Eribulin in Metastatic Breast Cancer
Dr. O'Shaughnessy Describes the School of Breast Oncology
Dr. O'Shaughnessy on the Future of TNBC Treatment
Dr. O'Shaughnessy on the Future of Breast Cancer
Dr. O'Shaughnessy on Breast Cancer Biomarkers
Dr. O'Shaughnessy on Negative TNBC Iniparib Results
Dr. O'Shaughnessy on Avastin as Her Standard of Care
Dr. O'Shaughnessy on Continued Access to Avastin
Oncology Specialists
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Karen Hagemaster, RN, BSN
Andy Hahn, MD
Missak Haigentz, MD
Susan Halabi, PhD
Ingfrid Haldorsen, MD
Mathew Hall, MD
Michael J. Hall, MD
Richard D. Hall, MD
Michael J. Hall, MD, MS
Balazs Halmos, MD
Balazs Halmos, MD, MS
Omid Hamid, MD
Omid A. Hamid, MD
Lana Hamieh, MD
Betty Hamilton, MD
Erika P. Hamilton, MD
Paul A. Hamlin, MD
Hans Hammers, MD, PhD
Hans J. Hammers, MD, PhD
M. Elizabeth Hammond, MD
Janet Hampton, RN, BS
Heather S. Han, MD
Daniel Haraf, MD
Melissa Hardesty, MD
Parameswaran Hari, MD, MRCP
Malini Harigopal, MD
Bridgett Harr, CNP
Richard Harris, MD
Simon J. Harrison, MBBS, PhD
Michael R. Harrison, MD
Lauren C. Harshman, MD
Lowell L. Hart, MD
Harold A. Harvey, MD
Mohammed Haseebuddin, MD
Mehmood Hashmi, MD
Raffit Hassan, MD
Khaled A. Hassan, MD, MS
Eric Haura, MD
Axel Hauschild, MD
Gerrit zur Hausen, MSc
Daniel F. Hayes, MD
John Hays, MD
Aiwu Ruth He, MD, PhD
Laurence J. Heifetz, MD
Volker Heinemann, MD, PhD
Josh H. Heinzerling, MD
Paul R. Helft, MD
Matthew D. Hellmann, MD
Brian Hemphill, MD
Jonathan Henderson, MD
Randal H. Henderson, MD, MBA
Andrew E. Hendifar, MD
Mary J. C. Hendrix, PhD
Tom Henricks
Thomas A. Hensing, MD
Elizabeth Petri Henske, MD
Martee L. Hensley, MD
Roy S. Herbst, MD, PhD
Alex Herrera, MD
Dawn L. Hershman, MD
Dawn L. Hershman, MD, MS
Thomas Herzog, MD
Paul J. Hesketh, MD
John V. Heymach, MD, PhD
Manuel Hidalgo, MD, PhD
Celestia Higano, MD
Celestia Higano, MD
Celestia S. Higano, MD
Celestia Higano, MD, FACP
Talal Hilal, MB, BCh
Brian T. Hill, MD, PhD
Fred R. Hirsch, MD, PhD
Alice Y. Ho, MD
Thai H. Ho, MD, PhD
Gabriela S. Hobbs, MD
Howard Hochster, MD, FACP
Howard S. Hochster, MD, FACP
Daniel Von Hoff, MD
Paulo Marcelo Hoff, MD, PhD
James E. Hoffman, MD
Karen E. Hoffman, MD
Jean Hoffman-Censits, MD
Craig Hofmeister, MD
Erin Wysong Hofstatter, MD
Patricia S. Hofstra
Christopher J. Hoimes, DO
Randall F. Holcombe, MD
Laura L. Holman, MD
Frankie Ann Holmes, MD
Sarah Holstein, MD, PhD
Jeffrey M. Holzbeierlein, MD
David S. Hong, MD
Waun K. Hong, MD
Axel Hoos, MD, PhD
Thomas Hope, MD
Thomas A. Hope, MD
Francoise Horand
Leora Horn, MD
Neil Horowitz, MD
Gabriel N. Hortobagyi, MD
Steven Horwitz, MD
Steven M. Horwitz, MD
Jing-Zhou Hou, MD, PhD
Kristie Howlett, MS, RN
James J. Hsieh, MD
James J. Hsieh, MD, PhD
Maung Myo Htut, MD
Jim C. Hu, MD
Jim Hu, MD, MPH
William C. Huang, MD
Clifford A. Hudis, MD
Kathryn E. Hudson, MD
Brandon Huffman, MD
Kevin S. Hughes, MD
Timothy P. Hughes, MD
Jeffrey Humphrey, MD
Kelly Hunt, MD
Jens Huober, MD
Arti Hurria, MD
Sara Hurvitz, MD
Sara A. Hurvitz, MD
Michael E. Hurwitz, MD, PhD
Hatim Husain, MD
Maha H. Hussain, MB ChB
Maha Hussain, MD, FACP
Maha H. Hussain, MD, FACP
Maha Hussain, MD, FACP, FASCO
Martin Hutchings, MD, PhD
Thomas E. Hutson, DO, PharmD
David Hyman, MD
Evolving HCC Treatment Paradigm: Combinations and Sequencing
Trending Now
Novel Therapies Show Significant Activity in Relapsed/Refractory ALL
Novel Therapies Surge Forward in Relapsed/Refractory Multiple Myeloma
New BTK Agents and Combinations Are on the Horizon for B-cell Malignancies
Myriad Modalities Advance Multiple Myeloma Paradigm
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
x
Subscribe